Successful use of bevacizumab in an adult primary diffuse leptomeningeal glioneuronal tumor.
Department of Neuro-Oncology, University and City of Health and Science Hospital, Turin, Italy - alessia.pellerino@alice.it.
Alessia
A
Pellerino
Department of Neuro-Oncology, University and City of Health and Science Hospital, Turin, Italy.
Roberta
R
Rudà
Department of Medical Sciences, University and City of Health and Science Hospital, Turin, Italy.
Luca
L
Bertero
Department of Neuro-Oncology, University and City of Health and Science Hospital, Turin, Italy.
Michela
M
Magistrello
Department of Neuro-Oncology, University and City of Health and Science Hospital, Turin, Italy.
Federica
F
Franchino
Department of Medical Sciences, University and City of Health and Science Hospital, Turin, Italy.
Paola
P
Cassoni
Department of Radiotherapy, University of Pisa, Pisa, Italy.
Francesco
F
Pasqualetti
Department of Neuroscience, University and City of Health and Science Hospital, Turin, Italy.
Lorenzo
L
Pinessi
Department of Radiological, Oncological and Anatomo-Pathological Sciences, Sapienza University, Rome, Italy.|IRCCS Neuromed, Pozzilli, Isernia, Italy.
Felice
F
Giangaspero
Department of Neuro-Oncology, University and City of Health and Science Hospital, Turin, Italy.
Riccardo
R
Soffietti
D000328:Adult; D000068258:Bevacizumab / Q000627:therapeutic use*; D001921:Brain / Q000473:pathology*; D006801:Humans; D008297:Male; D008577:Meningeal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D009422:Nervous System Diseases / Q000188:drug therapy*; D016896:Treatment Outcome; D014792:Visual Acuity / Q000502:physiology
D000068258:Bevacizumab